is an uncommon species causing invasive fungemia. This yeast is mainly associated with the colonisation of intravascular catheters, complicated intra-abdominal infections, and infections in the paediatric population. Here, we report a case of bloodstream infection in a 53-year-old man. He was admitted for an alcohol withdrawal syndrome and mild COVID-19. Among the primary risk factors for candidemia, only the use of broad-spectrum antimicrobials was reported. The empiric treatment was commenced with caspofungin and then targeted with intravenous fluconazole. Infective endocarditis was ruled out using echocardiography, and PET/TC was negative for other deep-seated foci of fungal infection. The patient was discharged after blood culture clearance and clinical healing. To the best of our knowledge, this is the first case of candidemia in a patient with COVID-19 and alcohol use disorder. We performed a systematic review of bloodstream infections caused by . Clinicians should be aware of the possibility of bloodstream infections in patients with alcohol use disorder, especially in a COVID-19 setting.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135169 | PMC |
http://dx.doi.org/10.3390/antibiotics12040691 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!